North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 15 of 15
Details
UPD
sitematrix Changed from 0 to
20/11/2023 12:38:14
(DavidS )
UPD
FurtherInformation Changed from
20mg/4.5mL concentrate for solution for infusion
Approved for the treatment of high-risk neuroblastoma in people aged 12 months and ove
20/11/2023 12:38:14
(DavidS )
UPD
Dinutuximab beta (Qarziba
®
) updated formatting
20/11/2023 12:38:14
(DavidS )
UPD
sitematrix Changed from 0 to
27/07/2022 14:48:45
(DavidS )
UPD
BlueTeq Changed from N to Y
27/07/2022 14:48:45
(DavidS )
UPD
FurtherInformation Changed from
20mg/4.5mL concentrate for solution for infusion
Approved for the treatment of high-risk neuroblastoma in people aged 12 months and over in line with NICE
to
27/07/2022 14:48:45
(DavidS )
UPD
Dinutuximab beta (Qarziba
®
) updated
27/07/2022 14:48:45
(DavidS )
UPD
sitematrix Changed from 0 to
26/04/2022 12:04:28
(DavidS )
UPD
FurtherInformation Changed from
20mg/4.5mL concentrate for solution for infusion
Approved for the treatment of high-risk neuroblastoma in people aged 12 months and over in line with NICE
to
20mg/4.5
26/04/2022 12:04:28
(DavidS )
UPD
Dinutuximab beta (Qarziba
®
) updated
26/04/2022 12:04:28
(DavidS )
UPD
Dinutuximab beta (Qarziba
®
) formatting updated
19/05/2021 16:44:36
(DavidS )
LDL
Link Added : NICE TA 538: Dinutuximab beta for treating neuroblastoma : https://www.nice.org.uk/guidance/ta538
24/01/2019 15:10:26
(DavidS )
UPD
Dinutuximab beta (Qarziba
®
) updated
24/01/2019 15:10:00
(DavidS )
UPD
Dinutuximab beta (Qarziba
®
) updated
24/01/2019 15:09:44
(DavidS )
ADD
Dinutuximab beta (Qaziba
®
) NICE TA538
24/01/2019 15:09:08
(DavidS )